BT Group has today confirmed the law firms on its new Legal Panel, which will be in place for the next 3 years. Firms on the panel will have the opportunity to bid for all external legal work across ...
Background Little is known about glucocorticoid-sparing agents in giant cell arteritis (GCA) except for IL-6 inhibition. Secukinumab (SEC) has shown significant improvements in the signs and symptoms ...